Early Inhaled Budesonide for the Prevention of Bronchopulmonary Dysplasia
2015; Massachusetts Medical Society; Volume: 373; Issue: 16 Linguagem: Inglês
10.1056/nejmoa1501917
ISSN1533-4406
AutoresDirk Bassler, Richard Plavka, Eric S. Shinwell, Mikko Hallman, Pierre‐Henri Jarreau, Virgilio Carnielli, Johannes N. van den Anker, Christoph Meisner, Corinna Engel, Matthias Schwab, Henry L. Halliday, Christian F. Poets,
Tópico(s)Infant Development and Preterm Care
ResumoSystemic glucocorticoids reduce the incidence of bronchopulmonary dysplasia among extremely preterm infants, but they may compromise brain development. The effects of inhaled glucocorticoids on outcomes in these infants are unclear.
Referência(s)